Literature DB >> 3044373

The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision?

R A DeRemee1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044373     DOI: 10.1002/art.1780310821

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  23 in total

1.  Systemic vasculitis.

Authors:  D D'Cruz; G Hughes
Journal:  BMJ       Date:  1992-02-01

Review 2.  [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement].

Authors:  M Laudien; P Ambrosch; A Till; R Podschun; P Lamprecht
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

Review 3.  Antineutrophil cytoplasmic antibody--a useful serological marker for vasculitis.

Authors:  J A Goeken
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

Review 4.  Pulmonary vasculitis.

Authors:  A Burns
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 5.  Wegener's granulomatosis. Thoughts and observations of a pathologist.

Authors:  F Wegener
Journal:  Eur Arch Otorhinolaryngol       Date:  1990       Impact factor: 2.503

6.  Relapsing Wegener's granulomatosis: successful treatment with cyclosporin-A.

Authors:  C Georganas; D Ioakimidis; C Iatrou; B Vidalaki; K Iliadou; P Athanassiou; T Kontomerkos
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

Review 7.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

8.  Stage-adapted treatment of Wegener's granulomatosis. First results of a prospective study.

Authors:  D Steppat; W L Gross
Journal:  Klin Wochenschr       Date:  1989-07-03

Review 9.  Pharmacological therapy for Wegener's granulomatosis.

Authors:  Eric S White; Joseph P Lynch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

10.  Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration.

Authors:  M Blank; Y Tomer; M Stein; J Kopolovic; A Wiik; P L Meroni; G Conforti; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.